Trending...
- California: Governor Newsom announces appointments 9.10.25 - 195
- John Thomas calls for unity and prayer after tragic loss - 165
- Ayurveda, Ayurvedic medical Science and Ayurvedic Therapies, Dr.Abhay Kumar Pati - 158
A plate-based fluorometric assay designed to screen, study and characterize potential inhibitors of CD38 cyclase activity.
MILPITAS, Calif. - Californer -- Cluster of differentiation 38 (CD38), also known as cyclic ADP ribose hydrolase or ADP-ribosyl cyclase is a multifunctional enzyme that catalyzes the synthesis and hydrolysis of Nicotinamide Adenine Dinucleotide (NAD) to Nicotinamide and ADP-ribose (ADPR). Additionally, CD38 generates second messengers, cyclic ADP-ribose using NAD as the substrate. Due to its role in NAD+ metabolism, the study of CD38 and its functions has been of great importance.
It is found on the surface of many immune cells, including plasma B cells, natural killer cells, CD4+, CD8+, etc. Elevated levels of CD38 are associated with aging, obesity, diabetes, heart disease, asthma, inflammation and tumorigenesis etc. BioVision's CD38 (Cyclase) Inhibitor Screening Kit is a plate-based fluorometric assay designed to screen, study and characterize potential inhibitors of CD38 cyclase activity. The assay utilizes a selective CD38 substrate to generate a fluorescent signal measured at Ex/Em = 300/410 nm.
More on The Californer
In the presence of potential CD38 cyclase inhibitors, the fluorescent signal is reduced. The assay is quick, easy, and sensitive for high-throughput screening of CD38 inhibitors. Additionally, the kit includes a CD38 Inhibitor as a control inhibitor.
Figure: Inhibition of CD38 cyclase activity by Quercetin. IC50 was calculated to be 5.2 ± 0.8 μM. Assay was performed following the kit protocol.
Storage Conditions -20ºC
USAGE For Research Use Only! Not For Use in Humans.
For more information on this Assay Kit Cat# K2102 https://bit.ly/30wP71F
It is found on the surface of many immune cells, including plasma B cells, natural killer cells, CD4+, CD8+, etc. Elevated levels of CD38 are associated with aging, obesity, diabetes, heart disease, asthma, inflammation and tumorigenesis etc. BioVision's CD38 (Cyclase) Inhibitor Screening Kit is a plate-based fluorometric assay designed to screen, study and characterize potential inhibitors of CD38 cyclase activity. The assay utilizes a selective CD38 substrate to generate a fluorescent signal measured at Ex/Em = 300/410 nm.
More on The Californer
- Car Wash Deal in Downey CA Prices Starting from $8
- Dr. Vincent Malfitano Elected to Central Council of The Italian Catholic Federation, National Gov
- Your Body Isn't Broken—It's Out of Balance: The New Book Revealing the Blueprint to Restore Hormone Balance, Sleep, Gut & Metabolic Health
- Long Beach Recognizes September as National Preparedness Month, Relaunches Program to Connect Neighborhoods to Disaster Planning Resources
- SEEAG Adds Santa Barbara County Office, Student & Community Agriculture Learning Programs
In the presence of potential CD38 cyclase inhibitors, the fluorescent signal is reduced. The assay is quick, easy, and sensitive for high-throughput screening of CD38 inhibitors. Additionally, the kit includes a CD38 Inhibitor as a control inhibitor.
Figure: Inhibition of CD38 cyclase activity by Quercetin. IC50 was calculated to be 5.2 ± 0.8 μM. Assay was performed following the kit protocol.
Storage Conditions -20ºC
USAGE For Research Use Only! Not For Use in Humans.
For more information on this Assay Kit Cat# K2102 https://bit.ly/30wP71F
Source: BioVision Inc
0 Comments
Latest on The Californer
- Youth Take the Lead: Kopp Foundation for Diabetes Hosts "By Youth, For Youth, With T1D" Gala on October 8 at Blue Bell Country Club
- Wise Business Plans Launches Business Plan Writing Services in San Diego to Propel Entrepreneurs
- Green Office Partner Named #1 Best Place to Work in Chicago by Crain's for 2025
- Apex Raises $200 Million Series D Financing
- CCHR, a Mental Health Watchdog Organization, Hosts Weekly Events Educating Citizens on Important Mental Health Issues
- "Leading From Day One: The Essential Guide for New Supervisors" Draws from 25+ Years of International Management Experience
- New Slotozilla Project Explores What Happens When the World Goes Silent
- Long Beach City Council Adopts Fiscal Year 2026 Budget
- Lights, Camera, Action Underway as The 23rd Oakland International Film Festival Shines Spotlight on Justice, Healing & Community
- California: Governor Newsom announces appointments 9.11.25
- The Two Faces of Charles D. Braun: How the Novel, Posthumously Yours, Came to Life
- Eastwood Ranch Foundation Hosts Annual Benefit 'Wags & Wishes' on 9/20
- Singer-Songwriter Ben Kaplan is Ready to Share His Intimate Music with the World
- California: Governor Newsom honors fallen State Correctional Officer Townsend
- Author Tells Why Trump is the Worst Profiteering US President in History
- The Legend of Sky City: A Sci-Fi Epic Begins
- Dr. Agus Sudjianto Joins Indemnify AI
- Ventura College Launches County's First Speech-Language Pathology Assistant Program
- Invictus Inc Prepares Backpack & School Supply Donation for Oakland Students
- iPOP Alum Lucas Adams to Star as Noah Newman in "The Young & The Restless"